Maternal Screening External Quality Assessment

The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down's syndrome, Spina Bifida and Trisomy 18.

  • Accredited to ISO/IEC 17043
  • Lyophilised for enhanced stability
  • 100% human serum
  • Monthly reporting
  • Submit results and view reports online via RIQASNet
  • Register up to five instruments at no extra cost
  • Suitable for first and second trimester screening
Cat No Kit Size Frequency Cycle Start Analytes
RQ9137 Expand 12 x 1ml Monthly (1 x 12 month cycle) January 6


  • AFP
  • Inhibin A
  • hCG, free beta
  • PAPP-A
  • hCG, total
  • Unconjugated Oestriol